GPC3 immunohistochemistry has become recognized as a clinically helpful diagnostic marker for pathologists to distinguish hepatocellular carcinoma from benign hepatocellular tumors and from many non-hepatocellular neoplasms [3]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.